JF Apperley
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation 15
- Chronic Myeloid Leukemia Treatments 8
- Acute Myeloid Leukemia Research 4
- Genetics top 5%
- Virus-based gene therapy research 3
- Transplantation top 5%
- Immunology top 10%
- T-cell and B-cell Immunology 3
-
- Acute Lymphoblastic Leukemia research 4
-
- Pluripotent Stem Cells Research 3
-
- Neutropenia and Cancer Infections 3
- Co-authors
- Aloïs GratwohlJM GoldmanPer LjungmanDietger NiederwieserDA WilliamsRichard SzydloTapani RuutuGèrard Socié
- Cited by
- HematologyGeneticsTransplantation
- Partner nations
- United KingdomSwitzerlandItaly
In The Last Decade
JF Apperley
25 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 58
- Hematology 963
- Genetics 253
- Transplantation 58
- Immunology 317
- Public Health, Environmental and Occupational Health 361
Countries citing papers authored by JF Apperley
This map shows the geographic impact of JF Apperley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JF Apperley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JF Apperley more than expected).
Fields of papers citing papers by JF Apperley
This network shows the impact of papers produced by JF Apperley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JF Apperley. The network helps show where JF Apperley may publish in the future.
Co-authorship network
The 25 scholars most cited alongside JF Apperley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | Reduced intensity conditioned allografts for myeloma : A study from the Chronic Leukaemia Working Party of the EBMT. | 2002 | 1 |
| 3 | Combination chemotherapy for systemic AL amyloidosis | 2001 | 1 |
| 4 | 2001 | 233 | |
| 5 | 2000 | 28 | |
| 6 | 1999 | 20 | |
| 7 | 1998 | 201 | |
| 8 | 1998 | 87 | |
| 9 | 1998 | 19 | |
| 10 | 1997 | 92 | |
| 11 | 1997 | 41 | |
| 12 | 1997 | 14 | |
| 13 | 1997 | 49 | |
| 14 | 1993 | 75 | |
| 15 | 1993 | 68 | |
| 16 | 1992 | 1 | |
| 17 | 1992 | 36 | |
| 18 | 1991 | 7 | |
| 19 | 1991 | 67 | |
| 20 | 1988 | 85 |
About JF Apperley
JF Apperley is a scholar working on Hematology, Immunology and Otorhinolaryngology, having authored 26 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (15 papers), Chronic Myeloid Leukemia Treatments (8 papers), Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Virus-based gene therapy research (3 papers), Pluripotent Stem Cells Research (3 papers), Neutropenia and Cancer Infections (3 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Hematology (963 citations), Genetics (253 citations) and Transplantation (58 citations). JF Apperley has collaborated with scholars based in United Kingdom, Switzerland and Italy. Frequent co-authors include Aloïs Gratwohl, JM Goldman, Per Ljungman, Dietger Niederwieser, DA Williams, Richard Szydlo, Tapani Ruutu, Gèrard Socié, HJ Kolb and R Powles. Their work appears in journals such as Blood, Bone Marrow Transplantation, British Journal of Cancer, Stem Cells and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.